Sofosbuvir and Ribavirin in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection

NCT01682720 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

421

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: SOF
DRUG: RBV
DRUG: Placebo to match SOF
DRUG: Placebo to match RBV

Sponsor

Gilead Sciences